+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contract Pharmaceutical Manufacturing, Research, and Packaging Market Forecasts to 2029

  • PDF Icon

    Report

  • 143 Pages
  • August 2024
  • Region: Global
  • BCC Research
  • ID: 5410378
Description Jump to:

This report aims to provide in-depth knowledge of the global pharmaceutical contract manufacturing, research, and packaging market, both in terms of qualitative and quantitative data, to help readers develop and assess the market landscape business/growth strategies, analyze their market position in the current marketplace, and make informed business decisions regarding pharmaceutical contract manufacturing, research, and packaging. The report estimates market size data for 2023 (the base year) and forecasts values for 2024 through 2029.

The contract manufacturing segment is analyzed by product type, dosage form, drug molecule type, drug delivery technologies, and region.

The contract research market is analyzed based on discovery, preclinical, and clinical research functional services.

The contract packaging market covers primary, secondary, and tertiary packaging. Primary packaging are categorized as bottles and vials, blisters, and others (e.g., prefilled-syringes, inhalers, caps and closures, dosing droppers, labels, and accessories) to analyze the primary packaging market.

Industry growth trends, drivers, restraints, and opportunities in the pharmaceutical contract manufacturing, research, and packaging market are also discussed in detail. The scope of the study is global. The report analyzes each market and its application, new products and advancements, market projections, and market shares.

Market Forecasts and Industry Dynamics

The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029. Contract manufacturers currently play central roles in pharmaceutical manufacturing. Fierce competition, stringent regulations, patent expirations and pressure to reduce drug development and manufacturing costs drive the pharmaceutical outsourcing market. The roles of outsourcing partners have evolved from mere auxiliary support to leaders of innovation. Large bio/pharma companies contribute the majority share of the contract development and manufacturing organization (CDMO) market due to commercial manufacturing activity. Small biotech companies account for a larger share of the molecule pipeline, incorporating outsourcing into their business models to conserve capital resources and expedite speed to market.

The contract manufacturing services market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $123.6 billion in 2023 to reach $183.3 billion by 2029, at a CAGR of 7% from 2024 through 2029. Strict regulatory environments are making the drug development process an increasingly difficult task. Technological challenges force drug developers to think creatively regarding innovations and business models. The pharmaceutical industry collaborates with different outsourcing providers throughout the research and development cycle of new products to meet these challenges.

The contract research services market for contract pharmaceutical manufacturing, research, and packaging is estimated to increase from $72.4 billion in 2023 to reach $104.1 billion by 2029, at a CAGR of 6.3% from 2024 through 2029. The pharmaceutical contract packaging industry is directly related to the demand and sales of pharmaceutical products. The growing pharmaceuticals market, the demand for advanced packaging solutions, the need for specialized packaging equipment and expertise, along with regulatory compliance and cost efficiency drive the pharmaceutical contract manufacturing market. The demand for timely commercial packaging services for low-volume drugs (e.g., niche, orphan products) is also increasing.

The report includes:

  • 67 data tables and 41 additional tables
  • Analysis of the global markets for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging services
  • Analyses of global market trends, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
  • Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by drug type, dosage form, formulation type, application, and region
  • Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
  • Review of the industry supply chain, using the Porter’s Five Forces and PESTLE models, to analyze the prevailing micro- and macro environmental factors
  • Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
  • A look at the recent patents
  • An analysis of the industry structure, including companies’ market shares, alliances, M&A activity and venture funding outlook
  • Company profiles of major players within the industry, including Lonza, Thermo Fisher Scientific Inc., WuXi AppTec, Catalent Inc., IQVIA Inc., and ICON plc

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Outsourcing Benefits
  • Outsourcing Drawbacks
  • Contract Manufacturing
  • Contract Manufacturing Types
  • Criteria for Evaluating a Contract Manufacturer
  • Core Functional Areas Requiring Constant Attention
  • Common Metrics for Selecting an Outsourcing Partner for Pharmaceutical Manufacturing
  • Top Sources of Dissatisfaction of Client or Contract Giver
  • Contract Research
  • Selecting a Contract Research Organization
  • Contract Packaging
  • Key Considerations When Choosing a Contract Packager
  • Need of a Contract Packager
Chapter 3 Market Dynamics
  • Market Dynamics Snapshot
  • Market Drivers
  • Resilient Pharmaceutical Demand
  • Need for Speed to Market
  • Shift to More Complex Oral Therapies
  • Significant Growth in Biologics and Cell and Gene Therapy Market
  • Rising Demand for Highly Potent Application Program Interfaces (HPAPI)s
  • Growing Demand for Generics and Biosimilars
  • Market Restraints
  • Strict Regulations and Compliance Requirements
  • Biotech Funding Challenges
  • Persistent Geopolitical Tension and Supply Chain Risks
  • Shortage of Skilled Personnel
  • Market Trends
  • Shift in Role of CDMOs from Service Providers to Strategic Partners
  • Sustainability
  • Increasing Consolidation
Chapter 4 Emerging Technologies and Developments
  • Contract Manufacturing
  • Increased Use of Digital Automation
  • Flexible Manufacturing
  • Continuous Flow Manufacturing
  • Expansion of Single-Use Technologies
  • Contract Research
  • Innovative Trial Design
  • Decentralized and Hybrid Clinical Trials
  • Real World Evidence
  • Increased Use of Artificial Intelligence and Machine Learning
  • Functional Service Partnership Model
  • Accelerating Global Rare Disease Research
  • Contract Packaging
  • Sustainable Packaging
  • Smart Packaging
Chapter 5 Market Segmentation Analysis
  • Segmentation Breakdown
  • Contract Manufacturing Market by Product Type
  • Drug Substances
  • Drug Products
  • Drug Products Market by Dosage Form Type
  • Drug Product Market by Drug Delivery System Type
  • Contract Manufacturing Market by Drug Molecule Type
  • Small Molecule Drugs
  • Biologics
  • Advanced Therapies
  • Contract Manufacturing Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Contract Research Market by Functional Service Type
  • Drug Discovery
  • Preclinical Development
  • Clinical Development
  • Contract Research Market by Therapeutic Area
  • Oncology
  • Immunology and Inflammation
  • Neurology
  • Cardiovascular
  • Others
  • Contract Research Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Contract Packaging Market by Service Type
  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging
  • Geographic Breakdown
  • Contract Packaging Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Contract Manufacturing
  • Overview
  • Market Shares
  • CMO Business Models
  • Contract Research
  • Overview
  • Market Shares
  • CRO Business Models
  • Contract Packaging
  • Overview
  • Recent Mergers and Acquisition
Chapter 7 Appendix
  • Methodology
  • Sources
  • Acronyms
Chapter 8 Company Profiles
  • Amcor plc
  • Catalent Inc.
  • Charles River Laboratories
  • ICON plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza
  • Pfizer Inc.
  • SCHOTT Pharma
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec
  • WestRock Co.
List of Tables
Summary Table: Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, by Segment, Through 2029
Table 1: Global Market for Contract Manufacturing Services, by Product Type, Through 2029
Table 2: Global Market for Contract Manufacturing of Drug Substances, by Region, Through 2029
Table 3: Global Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
Table 4: Global Market for Contract Manufacturing of Solid Dosage Forms, by Formulation, Through 2029
Table 5: Global Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 6: Global Market for Contract Manufacturing of Non-Sterile Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 7: Global Market for Contract Manufacturing of Sterile Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 8: Global Market for Contract Manufacturing of Semi-Solid Dosage Forms, by Formulation, Through 2029
Table 9: Global Market for Contract Manufacturing, by Drug Delivery System Type, Through 2029
Table 10: Global Market for Contract Manufacturing of Advanced Drug Delivery Systems, by Technology, Through 2029
Table 11: Global Market for Contract Pharmaceutical Manufacturing, by Drug Molecule Type, Through 2029
Table 12: Global Market for Contract Pharmaceutical Manufacturing, by Region, Through 2029
Table 13: North American Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
Table 14: North American Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
Table 15: North American Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
Table 16: North American Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 17: North American Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
Table 18: European Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
Table 19: European Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
Table 20: European Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
Table 21: European Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 22: European Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
Table 23: Asia-Pacific Market for Contract Pharmaceutical Manufacturing, by Country, Through 2029
Table 24: Asia-Pacific Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
Table 25: Asia-Pacific Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
Table 26: Asia-Pacific Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 27: Asia-Pacific Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
Table 28: Rest of the World Market for Contract Pharmaceutical Manufacturing, by Region, Through 2029
Table 29: Rest of the World Market for Contract Pharmaceutical Manufacturing, by Product Type, Through 2029
Table 30: Rest of the World Market for Contract Manufacturing of Drug Products, by Dosage Form Type, Through 2029
Table 31: Rest of the World Market for Contract Manufacturing of Liquid Drug Dosage Forms, by Formulation, Through 2029
Table 32: Rest of the World Market for Contract Manufacturing of Drug Products, by Drug Delivery System Type, Through 2029
Table 33: Drug Development Process
Table 34: Global Market for Contract Research Services, by Functional Service, Through 2029
Table 35: Drug Discovery Stages
Table 36: Clinical Phase Description
Table 37: Global Market for Contract Research Services, by Therapeutic Area, Through 2029
Table 38: Global Market for Contract Research Services, by Region, Through 2029
Table 39: North American Market for Contract Research Services, by Functional Service, Through 2029
Table 40: North American Market for Contract Research Services, by Country, Through 2029
Table 41: European Market for Contract Research Services, by Functional Service, Through 2029
Table 42: European Market for Contract Research Services, by Country, Through 2029
Table 43: Asia-Pacific Market for Contract Research Services, by Functional Service, Through 2029
Table 44: Asia-Pacific Market for Contract Research Services, by Country, Through 2029
Table 45: Rest of the World Market for Contract Research Services, by Functional Service, Through 2029
Table 46: Rest of the World Market for Contract Research Services, by Sub-Region, Through 2029
Table 47: Global Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
Table 48: Global Market for Primary Contract Pharmaceutical Packaging Services, by Product Type, Through 2029
Table 49: Global Market for Contract Pharmaceutical Packaging Services, by Region, Through 2029
Table 50: North American Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
Table 51: North American Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
Table 52: European Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
Table 53: European Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
Table 54: Asia-Pacific Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
Table 55: Asia-Pacific Market for Contract Pharmaceutical Packaging Services, by Country, Through 2029
Table 56: Rest of the World Market for Contract Pharmaceutical Packaging Services, by Service Type, Through 2029
Table 57: Rest of the World Market for Contract Pharmaceutical Packaging Services, by Region, Through 2029
Table 58: Selected Mergers and Acquisitions in the Contract Pharmaceutical Research, Manufacturing and Packing Industry, 2022-2024
Table 59: Report Sources
Table 60: Glossary of Terms Used in Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging
Table 61: Amcor Plc: Company Snapshot
Table 62: Amcor Plc: Financial Performance, FY 2022 and 2023
Table 63: Amcor Plc: Product Portfolio
Table 64: Amcor Plc: News/Key Developments, 2022-2024
Table 65: Catalent Inc.: Company Snapshot
Table 66: Catalent Inc.: Financial Performance, FY 2022 and 2023
Table 67: Catalent Inc.: Product Portfolio
Table 68: Catalent Inc.: News/Key Developments, 2022-2024
Table 69: Charles River Laboratories: Company Snapshot
Table 70: Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 71: Charles River Laboratories: Product Portfolio
Table 72: Charles River Laboratories: News/Key Developments, 2022-2024
Table 73: ICON Plc: Company Snapshot
Table 74: ICON Plc: Financial Performance, FY 2022 and 2023
Table 75: ICON Plc: Product Portfolio
Table 76: ICON Plc: News/Key Developments, 2023 and 2024
Table 77: IQVIA Inc.: Company Snapshot
Table 78: IQVIA Inc.: Financial Performance, FY 2022 and 2023
Table 79: IQVIA Inc.: Product Portfolio
Table 80: Laboratory Corporation of America Holdings: Company Snapshot
Table 81: Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 82: Laboratory Corporation of America Holdings: Product Portfolio
Table 83: Laboratory Corporation of America Holdings: News/Key Developments, 2023 and 2024
Table 84: Lonza: Company Snapshot
Table 85: Lonza: Financial Performance, FY 2022 and 2023
Table 86: Lonza: Product Portfolio
Table 87: Lonza: News/Key Developments, 2022-2024
Table 88: Pfizer Inc.: Company Snapshot
Table 89: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 90: Pfizer Inc: Product Portfolio
Table 91: Pfizer Inc.: News/Key Developments, 2022
Table 92: SCHOTT Pharma: Company Snapshot
Table 93: SCHOTT Pharma: Financial Performance, FY 2022 and 2023
Table 94: SCHOTT Pharma: Product Portfolio
Table 95: Table 95 SCHOTT Pharma: News/Key Developments, 2023 and 2024
Table 96: Thermo Fisher Scientific Inc.: Company Snapshot
Table 97: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 98: Thermo Fisher Scientific Inc: Product Portfolio
Table 99: Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
Table 100: WuXi AppTec: Company Snapshot
Table 101: WuXi AppTec Financial Performance, FY 2022 and 2023
Table 102: WuXi AppTec: Product Portfolio
Table 103: WuXi AppTec: News/Key Developments, 2022-2024
Table 104: WestRock Co.: Company Snapshot
Table 105: WestRock Co. Financial Performance, FY 2022 and 2023
Table 106: WestRock Co.: Product Portfolio
Table 107: WestRock Co.: News/Key Developments, 2022-2024

List of Figures
Summary Figure: Global Market for Contract Pharmaceutical Manufacturing, Research and Packaging, by Segment, 2021-2029
Figure 1: CDMO Market Segmentations, by Service, Molecule and End Use
Figure 2: Basic CDMO Service
Figure 3: Pharmaceutical Research and Development Continuum
Figure 4: Market Dynamics of Contract Pharmaceutical Manufacturing, Research and Packaging
Figure 5: Drug Approval Timeline
Figure 6: Industry Clinical Trial Success Rates, New Molecular Entities Only, 2020
Figure 7: Novel FDA-Approved Drugs, by Type, 2018-2023
Figure 8: Venture Capital Investment in Biopharma, 2020-2023
Figure 9: Pharma 4.0 Benefits to Pharmaceutical Companies
Figure 10: Global Market Shares of Contract Manufacturing Services, by Product Type, 2023
Figure 11: Global Market Shares of Contract Manufacturing of Drug Substances, by Region, 2023
Figure 12: Global Market Shares of Contract Manufacturing, by Drug Delivery System Type, 2023
Figure 13: Global Market Shares of Contract Manufacturing of Advanced Drug Delivery Systems, by Technology, 2023
Figure 14: Advanced Drug Delivery Systems, by Technology
Figure 15: Conventional vs. Advanced Dosage Forms
Figure 16: Global Market Shares of Contract Pharmaceutical Manufacturing, by Drug Molecule Type, 2023
Figure 17: Global Market for Contract Pharmaceutical Manufacturing, by Region, 2021-2029
Figure 18: Global Market Shares of Contract Pharmaceutical Manufacturing, by Region, 2023
Figure 19: Distribution Share of R&D Investment in Drug Development, by Function, 2020
Figure 20: Global Market Shares of Contract Research Services, by Functional Service, 2023
Figure 21: Clinical Development Services Offered, by CROs
Figure 22: Global Market Shares of Contract Research Services, by Therapeutic Area, 2023
Figure 23: Global Market Shares of Contract Research Services, by Region, 2023
Figure 24: Share of Clinical Trials Started from 2019 through 2023, by Region
Figure 25: Global Market Shares of Contract Pharmaceutical Packaging Services, by Service Type, 2023
Figure 26: Global Market Shares of Contract Pharmaceutical Packaging Services, by Region, 2023
Figure 27: Global Market Shares of Contract Manufacturing Services, by Top Companies, 2023
Figure 28: CMO Business Models
Figure 29: Global Market Shares of Contract Research Services, by Top Companies, 2023
Figure 30: CRO Business Models
Figure 31: Amcor Plc: Revenue Share, by Business Unit, FY 2023
Figure 32: Amcor Plc: Revenue Share, by Region, FY 2023
Figure 33: Catalent Inc.: Revenue Share, by Business Unit, FY 2023
Figure 34: Catalent Inc.: Revenue Share, by Country/Region, FY 2023
Figure 35: Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 36: Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 37: ICON Plc: Revenue Share, by Country/Region, 2023
Figure 38: IQVIA Inc.: Revenue Share, by Business Unit, 2023
Figure 39: IQVIA Inc.: Revenue Share, by Region, 2023
Figure 40: Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, 2023
Figure 41: Laboratory Corporation of America Holdings: Revenue Share, by Region, 2023
Figure 42: Lonza: Revenue Share, by Business Unit, FY 2023
Figure 43: Lonza: Revenue Share, by Region, FY 2023
Figure 44: Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 45: Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 46: SCHOTT Pharma: Revenue Share, by Business Unit, 2023
Figure 47: SCHOTT Pharma: Revenue Share, by Region, 2023
Figure 48: Thermo Fisher Scientific Inc.: Market Share, by Business Unit, 2023
Figure 49: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Figure 50: WuXi AppTec: Revenue Share, by Business Unit, FY 2023
Figure 51: WuXi AppTec: Revenue Share, by Country/Region, FY 2023
Figure 52: WestRock Co.: Revenue Share, by Business Unit, FY 2023
Figure 53: WestRock Co.: Revenue Share, by Country/Region, FY 2023

Samples

Loading
LOADING...

Companies Mentioned

  • Amcor plc
  • Catalent Inc.
  • Charles River Laboratories
  • ICON plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza
  • Pfizer Inc.
  • SCHOTT Pharma
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec
  • WestRock Co.

Table Information

Report AttributeDetails
No. of Pages143
PublishedAugust 2024
Forecast Period2023 - 2029
Estimated Market Value ( USD ) in 2023 $ 212.2 Billion
Forecasted Market Value ( USD ) by 2029 $ 310.2 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

CDMO Market Opportunities and Competitive Landscape - Product Image

CDMO Market Opportunities and Competitive Landscape

  • Report
  • 130 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users, Region - Global Forecast to 2029 - Product Image

Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users, Region - Global Forecast to 2029

  • Report
  • 385 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions - Product Image

Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions

  • Report
  • 545 Pages
  • Global
From
Contract Development and Manufacturing Organization Market: Analysis By Type, By Product, By Sourcing, By Application, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Product Image

Contract Development and Manufacturing Organization Market: Analysis By Type, By Product, By Sourcing, By Application, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029

  • Report
  • 180 Pages
  • Global
From
GMP Testing Service - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

GMP Testing Service - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 121 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.